Besides, side populations of glioblastoma cells (U251 and primary glioblastoma sample) were less sensitive to HSV-TK/GCV system than the non-side population [45], indicating that GFAP-positive cells may not be fully ablate under GCV treatment in our study. This evidence concerns the gene TKT and glioblastoma.